Acute toxicity and cardio-respiratory effects of 2-deoxy-D-glucose: A promising radio sensitiser

Biomedical and Environmental Sciences

Volumn 19, Issue 2, 2006, Pages 96-103

  Vijayaraghavan, R ^a   Kumar, Deo ^a   Dube, S N ^a   Singh, R ^a   Pandey, K S ^a   Bag, B C ^a   Kaushik, M P ^a   Sekhar, K ^a   Dwarakanath, B S ^b   Ravindranath, T ^b  

^a DEFENCE RESEARCH AND DEVELOPMENT ESTABLISHMENT   (India)

^b INSTITUTE OF NUCLEAR MEDICINE AND ALLIED SCIENCES   (India)

Author keywords

2 deoxy D glucose; Acute toxicity; Blood pressure; Glucose analogue; Heart rate; Radio sensitizer; Respiration

Indexed keywords

ANTIMETABOLITE; DEOXYGLUCOSE; GLUCOSE; RADIOSENSITIZING AGENT;

ANIMAL; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR FUNCTION; DRUG EFFECT; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; LUNG FUNCTION TEST; MOUSE; ORAL DRUG ADMINISTRATION; RAT; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTIMETABOLITES; BLOOD PRESSURE; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; CARDIOVASCULAR PHYSIOLOGY; DEOXYGLUCOSE; GLUCOSE; HEART RATE; INJECTIONS, INTRAVENOUS; MICE; RADIATION-SENSITIZING AGENTS; RATS; RATS, WISTAR; RESPIRATORY FUNCTION TESTS;

ANIMALIA;

EID: 33745172824     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Laszlo J, Harlan W R, Klein R F, et al. (1961). The effect of 2-deoxy-D-glucose infusions on lipid and carbohydrate metabolism in man. J Clin Invest 40, 171-176.
2. McComb R B, Yushok W D. Metabolism of ascites tumor cells. II effects of 2-deoxy-D-glucose phosphorylation on phosphorus metabolism. (1964). Cancer Res 254, 193-197.
3. Mattson M P, Duan W, Guo Z (2003). Meal size and frequency affect neuronal plasticity and vulnerability to disease: cellular and molecular mechanisms. J Neurochem 84, 417-431.
4. Dreau D, Morton D S, Foster M, et al. (1998). Effects of 2-deoxy-D-glucose administration on immune parameters in mice. Immunopharmacol 39, 201-213.
5. Tariq M, Arshaduddin M, Biary N, et al. (2002). 2-deoxy-D-glucose attenuates harmaline induced tremors in rats. Brain Res 945, 212-218.
6. Ebrahim A S, Babu E, Thirunavukkarasu C, et al. (2001). Protective role of vitamin E, 2-deoxy-D-glucose, and taurine on perchloroethylene induced alterations in ATPases. Drug Chem Toxicol 24, 429-437.
7. Lan Y W, Ishii Y, Palmer K E, B et al. (2003). 2-deoxy-D-glucose protects retinal ganglion cells against excitotoxicity. Neuroreport 14, 2369-2372.
8. Duke W W, Hirschowitz B I, Sachs G (1965). Vagal stimulation of gastric secretion in man by 2-deoxy-D-glucose. Lancet 2, 871-876.
9. Stadler G A, Schultheiss H R, Allogower M (1972). Use of 2-DG for testing completeness of vagotomy in man. Gastroenterol 63, 552-556.
10. Wei J, Cohen D M, Quast M J. (2003). Effects of 2-deoxy-d-glucose on focal cerbral ischemia in hyperglycemic rats. J. Cereb. Blood Flow Metab 23, 556-564.
11. Saydjari R, Upp JR Jr, Alexander RW, et al. (1989). 2-deoxy-D-glucose inhibits the antitumor effects of alpha-difluromethylornithine on the growth of colon cancer in vivo. Invest New Drugs 7, 131-138.
12. Landau B R, Laszalo J, Stengle J, et al. (1958). Certain metabolic and pharmacological effects in cancer patients given infusions of 2-deoxy-D-glucose. J. National Cancer Institute 21, 485-494.
13. Jain V K, Holtz G W, Pohlit W, et al. (1977). Inhibition of unscheduled DNA synthesis and repair of potentially lethal X-ray damage by 2-doxy-D-glucose in yeast. Int J Rad Oncol Biol Physiol 32, 175-180.
14. Dwarakanath B S, Jain V K. (1989). Energy linked modifications of the radiation response in a human cerebral glioma cell line. Int J Rad Oncol Biol Physiol 17 1033-1040.
15. Dwarakanath B S, Jain V (1991). Effects of gamma-rays and glucose analogs on the energy metabolism of a cell line derived from human cerebral glioma. Indian J Biochem Biophy 28, 203-209.
16. Jha B, Pohlit W (1992). Effect of 2-deoxy-D-glucose on DNA double strand break repair, cell survival and energy metabolism in euoxic Ehrlich ascites tumour cells. Int J Rad Biol 62, 409-415.
17. Mohanti B K, Rath G K, Anantha N, et al. (1996). Improving Cancer Radiotherapy with 2-Deoxy-D-Glucose: Phase I/II Clinical Trials on Human Cerebral Gliomas. Int J Rad Oncol Biol Physiol 35, 103-111.
18. Halicka H D, Ardelt B, Li X, et al. (1995). 2-Deoxy-D-glucose enhances sensitivity of human histiocytic lymphoma U937 cells to apoptosis induced by tumor necrosis factor. Cancer Res 55, 444-449.
19. Padilla-Paz I, Donart N J, Smith H O (2003). The effect of 2DG as a chemosensitizer and radiosensitizer on cervical cancer cells. Proc. Am Soc Clin Oncol p461.
20. Lin X, Zhang F, Bradbury CM, et al. (2003). 2-Deoxy-D-glucose induced cytotoxicity and radiosensitization in tumor cells is mediated via disruptions in thiol metabolism. Cancer Res 63, 3413-3417.
21. Maschek G, Savaraj N, Priebe W et al. (2004). 2-deoxy-D-glucose increases the efficacy of adriamycin and pacitaxel in human osteosarcoma and non-small cell lung cancers in vivo. Cancer Res 64, 31-34.
22. Bell S E, Quinn D M, Kellett G L et al. (1998). 2-deoxy-D-glucose preferentially kills multidrug-resistant human KB carcinoma cell lines by apoptosis. Brit J Cancer 78, 1464-1470.
23. Keenan J, Liang Y, Clynes M (2004). Two-deoxyglucose as an anti-metabolite in human carcinoma cell line RPMI-2650 and drug-resistant variants. Anticancer Res 24, 433-440.
24. Mack P, Ahren B, Jeppsson B et al. (1998). Influence of 2-deoxy-D-glucose and arterial ischaemia on glucose oxidation and growth of liver cancer in the rat. Eur J Cancer Clin Oncol 24, 1433-1437.
25. Hervias I, Lasheras B, Aguirre N (2000). Deoxy-D-glucose prevents and nicotinamide potentiates 3, 4-methylenedioxymethamphetamine-induced serotonin neurotoxicity. J Neurochem 75, 982-990
26. Thompson D A, Lilavivathana U, Campbell R G (1981). Suppression of prolactin and growth hormone responses to 2-deoxy-D-glucose-induced glucoprivation by mazindol in humans. Metabolism 30, 1015-1020.
27. Schurr A, Miller J J, Payne R S, et al. (1999). An Increase in Lactate Output by Brain Tissue Serves to Meet the Energy Needs of Glutamate-Activated Neurons. J Neurosci 19, 34-39.
28. Miller ES, Koebel DA, and Sonnenfeld G. (1993). The metabolic stressor 2-deoxy-D-glucose (2-DG) enhances LPS-stimulated cytokine production in mice. Brain Behav Immunol 7, 317-325.
29. Gad S C, Weil C S. (1989). Statistics for lexicologists. In: Hayes AW (Ed), Principles and Methods of Toxicology, second edition. Raven Press, New York, pp. 463-467.
30. Vijayaraghavan R, Thomson R, Schaper M., et al. (1994). Computer assisted recognition and quantification of sensory irritation, airway constriction and pulmonary irritation. Archiv Toxicol 68, 490-499.
31. 31P NMR and metabolic implications. Biochimie. 74, 867-873.
32. Nelson C A, Wang J Q, Leav I, Crane P D. (1996). The interaction among glucose transport, hexokinase, and glucose-6-phosphatase with respect to 3H-2-deoxyglucose retention in murine tumor models. Nuclear Med Biol 23, 533-541.
33. Chi M M, Pusateri M E, Carter JG, et al. (1987). Enzymatic assays for 2-deoxyglucose and 2-deoxyglucose 6-phosphate. Anal. Biochem. 161, 508-513.
34. Haga N, Naito M, Seimiya H, et al. (1998). 2-Deoxyglucose inhibits chemotherapeutic drug-induced apoptosis in human monocytic leukemia U937 cells with inhibition of c-Jun N-terminal kinase 1/stress-activated protein kinase activation. Int. J. Cancer. 76, 86-90.
35. Jain V K, Kalia V K, Gopinath PM, et al. (1979). Optimization of cancer therapy. part III - Effects of combining 2-deoxy-D-glucose treatment with gamma irradiation on normal mice. Indian J Exp Biol 17, 1320-1325.
36. Thompson D A, Lilavivathana U, Campbell R G (1980). Thermoregulatory and related responses to 2-DG administration in humans. Am J Physiol 239, 291-295.
37. Wan R, Camandola S, Mattson M P (2003). Intermittent fasting and dietary supplementation with 2-deoxy-D-glucose improve functional and metabolic cardiovascular risk factors in rats. FASEB J. 17, 1133-1134.
38. Abbink E J, Tack C J, Smits P (2001). Vascular effects of metabolic inhibition by 2-deoxy-D-glucose in humans. J Cardiovas Pharmacol 37, 94-100.
39. Breier A, Crane A M, Kennedy C, Sokoloff L (1993). The effects of pharmacologic doses of 2-deoxy-D-glucose on local cerebral blood flow in the awake, unrestrained rat. Brain Res 618, 277-282.
40. Singh S P, Singh S, Jain V (1990). Effects of 5-bromo-2-deoxyuridine and 2-deoxy-D-glucose on radiation induced micronuclei in mouse bone marrow. Int J Rad Biol 58, 791-797.